Financial Markets
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

Company - Domestic
 Search News  Or
Jilin Aodong Medicine posts 65.11% profit for 2011

Jan. 11, 2012 (China Knowledge) - State-owned Jilin Aodong Medicine Industry Group Co Ltd<000623>, one of the leading drug makers in Northeast China, reaped RMB 2.04 billion in net profit attributable to shareholders in 2011, reflecting a year-on-year increase of 65.11% from RMB 1.24 billion in 2010.

The growth was principally boosted by the company's investment return in GF Securities Co Ltd<000776>, a major brokerage firm in China, said the company.

Last year, the Shenzhen-listed firm's operating revenue reached RMB 1.15 billion, 3.17% more than RMB 1.11 billion it realized in 2010. Earnings per share were RMB 2.97, compared with nearly RMB 1.80 in 2010.

As of December 31, 2011, the drug maker had RMB 10.15 billion in total assets, whereas it had RMB 7.9 billion at the beginning of 2011, representing an increase of 26.48%.

Net asset value per share or NAVPS was RMB 13.19 at the end of 2011, 5.4% more than RMB 12.52 at the beginning of last year.

According to company's website, it had RMB 7.25 billion in net asset with debt/asset ratio of 8.26% as of December 31, 2010.

Add this     
Copyright © "2015"

Send feedback or comments to:

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services


 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved